Explore Our Publications
Entrada’s commitment to publications & transparency
Entrada is committed to publishing the results of our sponsored research in a transparent, scientifically accurate, and timely manner. Entrada will apply high ethical standards to our publications and presentations and will adhere to recognized industry guidance such as International Committee of Medical Journal Editors (ICMJE) Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals and International Society for Medical Publication Professionals (ISMPP) Good Publication Practice for Communicating Company Sponsored Medical Research.
Past Presentations
-
Endosomal Escape Vehicles (EEV) to Enhance the Functional Delivery of Oligonucleotides in Preclinical Models of Duchenne Muscular Dystrophy
- By: Mahasweta Girgenrath, PhD, Vice President Neuromuscular, Entrada Therapeutics
- At: 2023 MDA Clinical and Scientific Conference
- On: March 20, 2023
DownloadMarch 20, 2023 -
Exon Skipping and Dystrophin Production with a Novel EEV-Conjugated, Exon 45 Skip Amenable PMO in Preclinical Models of DMD
- By: Nelsa Estrella, PhD, Associate Director, Entrada Therapeutics
- At: 2023 MDA Clinical and Scientific Conference
- On: March 19, 2023
DownloadMarch 19, 2023 -
Endosomal Escape Vehicle-Oligonucleotide Conjugates for the Targeted Upregulation and Downregulation of Gene Expression
- By: Mahasweta Girgenrath, PhD, Vice President Neuromuscular, Entrada Therapeutics
- At: 8th Annual Annual Oligonucleotide & Precision Therapeutics Congress
- On: March 14, 2023
DownloadMarch 14, 2023 -
Development of Endosomal Escape Vehicles (EEV) to Enhance the Functional Delivery of Oligonucleotides
- By: Patrick Dougherty, PhD, Senior Scientist, Entrada Therapeutics
- At: Targeted Intracellular Delivery Summit
- On: March 8, 2023
DownloadMarch 8, 2023 -
Endosomal Escape Vehicles (EEV™) to Enhance the Functional Delivery of Oligonucleotides in Preclinical Models of Neuromuscular Diseases
- By: Mahasweta Girgenrath, PhD, Vice President Neuromuscular, Entrada Therapeutics
- At: https://solvefshd.com/
- On: March 2, 2023
DownloadMarch 2, 2023 -
Endosomal Escape Vehicle (EEV) Platform to Enhance the Functional Delivery of Oligonucleotides
- By: Leo Ziqing Qian, PhD, Co-Founder & Vice President, Discovery Research, Entrada Therapeutics
- At: TIDES EUROPE 2022
- On: November 17, 2022
DownloadNovember 17, 2022